Laboratory services

Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 348
A002 Cell Blood Count 27 1 923
A005 Sedimentation rate 16 1 140
A008 Reticulocytes 13 926
A009 Matching of blood and compatibility test 290 20 659
M125 Malaria test 67 4 773
URINE ANALYSIS
B500 Standard urine test 13 926
B502 Standard urine test with microscopy 24 1 710
B510 Urine pregnancy test (screening) 13 926
B511 Nechiporenko urine test 20 1 425
B512 Zimnitsky urine test 53 3 776
B513 3-portions urine test examination 40 2 850
B514 2-portions urine test examination 27 1 923
B515 Urine precipitate - Microscopy 13 926
B517 Creatinine Clearance 53 3 776
STOOL ANALYSIS
B306 Fecal examination for pancreatic elastase-1 52 3 704
M105 Coprology total 27 1 923
M110 Coprology (occult blood) 13 926
M111 Carbohydrates in faeces 40 2 850
M115 Enterobiasis 20 1 425
M120 Eggs of helminths (+protozoa) 27 1 923
M122 Protozoa in faeces 20 1 425
M390 Adenovirus and rotavirus (in stool) 28 1 995
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 2 921
M391 Helicobacter pylori(in stool) 27 1 923
M393 Verotoxin in stool 50 3 562
M394 Norovirus in stool 25 1 781
M395 Calprotectin in stool (quantitative) 50 3 562
M396 Clostridium Difficile Toxin A & B 65 4 631
SPUTUM ANALYSIS
M150 Standard sputum test 27 1 923
M002 Nasal slime general clinical research 27 1 923
M355 M. Tuberculosis in sputum 33 2 351
SKIN& NAIL PLATES
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 348
M210 Demodex folliculorum 20 1 425
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 686
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 425
M221 Standard Cervical Smear Test 20 1 425
M222 Standard Urethral Smear Test 20 1 425
M223 Standard prostatic fluid test 27 1 923
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 1 923
B621 Standard Serous Fluid test 27 1 923
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 351
B623 Glucose in cerebrospinal fluid 17 1 211
B624 Protein in cerebrospinal fluid 17 1 211
HEMOSTASIS SYSTEM
A020 APTT 16 1 140
A025 Prothrombin+INR 27 1 923
A027 Thrombin time 22 1 567
A030 Fibrinogen 16 1 140
A035 Antithrombin III 27 1 923
C139 Protein-C 47 3 348
C142 Protein-S 47 3 348
C515 D-DIMER 60 4 274
C305 Lupus anticoagulant (panel) 53 3 776
A033 Platelet Aggregation 83 5 913
A031 FACTOR VON 170 12 111
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 137
BLOOD DRUG RATES
B142 Folic acid 27 1 923
T010 Digoxin 78 5 557
T015 Determination of phenobarbital in blood 53 3 776
T020 Phenytoin 53 3 776
T025 Valproic Acid 53 3 776
T030 Carbamazepine 53 3 776
T080 Determination of tacrolimus in blood 55 3 918
T085 Levetiracetam (Keppra) 100 7 124
T097 Therapeutic drug monitoring of Topiramate 23 1 638
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 23 1 638
T100 Determination of the concentration of Amikacin in the blood 40 2 850
T101 The determination of the concentration of Gentamicin in the blood 40 2 850
T102 Determine the concentration of Vancomycin in the blood 40 2 850
NARCOTIC SCREENING
T035 Methamphetamine 33 2 351
T040 Cannabis 33 2 351
T045 Cocaine 33 2 351
T050 Opiates / QUICK TEST 33 2 351
T060 Сotinine 33 2 351
T070 Benzodiazepines 53 3 776
T075 Drug screening in urine 53 3 776
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 778
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 13 322
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 3 776
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 1 923
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 778
B003 Ceruloplasmin 50 3 562
B004 Eosinophil Cationic Protein (ECP) 50 3 562
B007 Cuprum 22 1 567
B100 Glucose 13 926
B101 Standard glucose tolerance test 33 2 351
B102 Vitamin D 107 7 623
B103 Vitamin A 83 5 913
B104 Vitamin B1 83 5 913
B105 Cholesterol 13 926
B107 Pregnancy glucose tolerance test 33 2 351
B108 Vitamin B5 83 5 913
B109 Vitamin B6 83 5 913
B110 Cholesterol-HDL 20 1 425
B112 Vitamin C 83 5 913
B113 Vitamin E 83 5 913
B114 Vitamin K 83 5 913
B115 Cholesterol-LDL 20 1 425
B118 Lactate 25 1 781
B120 Triglycerides 13 926
B122 Angiotensin converting enzyme (ACE) 48 3 419
B125 Bilirubin total 13 926
B130 Bilirubin direct 13 926
B135 Albumin 13 926
B137 Homocysteine 67 4 773
B140 Creatinine 13 926
B144 Zink 38 2 707
B145 Iron 16 1 140
B148 Litium 74 5 272
B150 Iron binding capacity 20 1 425
B155 Total protein 13 926
B160 Protein fractionation (Electrophoresis) 27 1 923
B165 Lipoprotein A 27 1 923
B166 APO-A-1 protein 27 1 923
B167 APO-B protein 27 1 923
B170 Urea 13 926
B175 Uric acid 13 926
B180 Fructosamine 20 1 425
B188 Determination of bile acids in blood 45 3 206
B200 Calcium (total) 16 1 140
B202 Calcium (ionised) 20 1 425
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 10 686
B205 Sodium/Potassium/Chloride 16 1 140
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 1 923
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 1 923
B210 Magnesium 13 926
B215 Phosphate inorganic 13 926
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 9 689
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 348
B219 Study of dialysate for electrolyte composition, pH, glucose 131 9 332
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 348
B300 Amylase 16 1 140
B305 Amylase pancreatic 16 1 140
B310 Lipase 16 1 140
B315 Lactatedehydrogenase (LDH) 13 926
B317 Erythropoietin 47 3 348
B320 Creatine Kinase 13 926
B325 Creatine Kinase MB 16 1 140
B330 Gamma Glutamyle Transferase (GGT) 13 926
B335 Acid phosphatase 16 1 140
B340 Alk. Phosphatase 13 926
B345 Alanine Amino Transferase (ALT) 13 926
B350 Aspartate Amino Transferase (AST) 13 926
B360 Cholinesterase 18 1 282
B362 Determination of C1 esterase inhibitor in blood 45 3 206
B400 C-Reactive Protein 20 1 425
B401 C-reactive protein high sensitivity 30 2 137
B405 Rheumatoid Factor 20 1 425
B410 Anti-streptolysin O titre 20 1 425
B411 Alfa-1-antitrypsin 27 1 923
C415 Ferritin 27 1 923
B430 Haemoglobin A1C 22 1 567
B435 Myoglobin 47 3 348
B440 Transferrin 27 1 923
B445 Troponin I 47 3 348
B450 Troponin T 47 3 348
B451 BNP (brain natriuretic peptide) 87 6 198
B556 The N-terminal peptide NT-proBNP 88 6 269
B604 Alpha-2-Macroglobuline 47 3 348
B610 Haptoglobin 47 3 348
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 9 261
B702 Procalcitonin (quant) 60 4 274
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 348
B025 Microproteinuria 13 926
B132 Urea (random portion) 12 855
B133 Uric acid (random portion) 12 855
B139 The content of Cu (copper) in the urine (a single portion of urine) 13 926
B173 Glucose (random portion) 13 926
B182 Alpha Amylase (random portion) 18 1 282
B505 NA+/K+/Cl (random portion) 20 1 425
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 686
B134 Calcium (random portion) 18 1 282
B008 The content of Cu (copper) in the urine (daily) 13 926
B703 Gas chromatography of urine (organic aciduria) 250 17 810
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 282
B141 Creatinine (24h) 18 1 282
B171 Urea (24h) 18 1 282
B176 Uric acid (24h) 18 1 282
B177 Phosphate inorganic (24h) 18 1 282
B178 Magnesium (24) 18 1 282
B179 Glucose (24h) 18 1 282
B183 Total Protein (24h) 18 1 282
B506 Na (24h) 20 1 425
B507 K (24h) 20 1 425
B508 Cl (24h) 20 1 425
B516 Calcium urine test (24h) 22 1 567
B550 Oxalate in urine 40 2 850
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 1 710
B562 Urine protein electrophoresis 40 2 850
B520 Stone chemistry - Profile 78 5 557
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 354
B420 Immunoglobulin M (IgM) 19 1 354
B425 Immunoglobulin G (IgG) 19 1 354
C299 Circulating Immune Complex 22 1 567
C300 IgE total 27 1 923
C285 Interferon sensibility state 293 20 873
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 14 248
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 14 248
C293 Compliment Componenta C3 33 2 351
C294 Compliment Componenta C4 33 2 351
C295 Neutrophilic Bactericidal Activity (HCT test) 27 1 923
C290 Interleukin 6 34 2 422
C291 Interleukin 8 34 2 422
C296 Interleukin 10 34 2 422
C298 Tumor Necrosis Factor 39 2 778
C281 Interleukin 1 Beta 50 3 562
C307 Determination of amyloid - beta (1-42) in blood and in cerebrospinal fluid 78 5 557
B704 Oligoclonal IgG in liquorrhea & serum 120 8 549
Diagnosis Of Auto-Immune Diseases
C023 Cardiolipin antibodies, IgM 50 3 562
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 5 913
C035 Cytoplasmic antigen antibodies Jo-1 (anti-Jo-1) 83 5 913
C101 Anti-smooth muscle antibodies (ASMA) 50 3 562
C102 Anti-mitochondrial antibodies (AMA) 50 3 562
C167 Determination of аntibodies to nuclear antigens (ANA), IgG, 25 antigens: nucleosomes, dsDNA, histones, Sm, RNP(68kD/A/C), Sm / RNP, SSA / Ro 60kD, SSA / Ro 52kD, SSB, Scl-70, Ku, PM-Scl 100, Mi-2, Jo-1, PL-7, PL-12, SRP, ribosomes, CENP-a / B, GP100, PC100, M2, M2/nPDC and f-actin; quality, with decoding 115 8 192
C168 Determination of аntibodies to liver antigens, IgG, 7 antigens: M2 / nPDC, gp210, sp100, LKM1, LC1, SLA, f-actin; with decoding 45 3 206
C169 Determination of аntibodies for diagnosis of polymyositis/ scleroderma, IgG, 8 antigens: Jo - 1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl-100, Scl-70; quality,  with decoding 75 5 343
C171 Determination of аntibodies to extractable nuclear antigens (ENA screen) and nucleosomes, IgG, 7 antigens: nucleosomes, Sm, Sm/RNP, SSA (Ro), SSB (La), Jo-1, Scl-70; quality,  with decoding 21 1 496
C175 Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 17 1 211
C176 Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 17 1 211
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 206
C203 Scl-70 antibodies 50 3 562
C225 Thyroglobulin antibody 33 2 351
C230 Thyroperoxidase antibody 33 2 351
C231 Auto AB TSH-receptor 53 3 776
C233 Antispermatic Antibodies 67 4 773
C235 AB Insulin IgG 40 2 850
C236 AB insular beta-cells 67 4 773
C240 Antibodies acetylcholine receptor 160 11 398
C241 Antibodies aquaporin 4( NMO) 80 5 699
C242 Antibodies skeletal muscles 70 4 987
C243 Antibodies gangliosides, blot 90 6 412
C244 Myositis antibodies, blot 90 6 412
C245 Anti-neuronal antibodies, blot 110 7 836
C246 Antibodies NMDA receptor 150 10 686
C247 Antibodies Sm 50 3 562
C248 Antibodies gliadine deamidated peptides IgG 45 3 206
C249 Antibodies gliadine deamidated peptides IgA 45 3 206
C250 Antibodies RNP-70 45 3 206
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 20 802
C253 Blood test on APG 105 7 480
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 51 3 633
C256 Definition of CD20 in peripheral blood 54 3 847
C257 Typing of CD-34 + cells 56 3 989
C258 Myelogram 122 8 691
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 83 5 913
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 83 5 913
C261 Determination of Tau protein in biological fluids 78 5 557
C262 Determination of glial fibrillar acid protein (GFAP) 106 7 551
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 493
C500 Nuclear antibody (IF) 47 3 348
C505 Cardiolipin antibody IgG 47 3 348
C506 Cardiolipin antibody IgA 25 1 781
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 20 517
C533 Anti-dsDNA 53 3 776
C534 Anti-ssDNA 53 3 776
C535 Phospholipid Antibody IgG 53 3 776
C536 Phospholipid Antibody IgM 53 3 776
C830 Antibodies Prothrombin 40 2 850
C840 Antibodies Gliadin IgA 40 2 850
C841 Anti-Transglutaminase IgG 47 3 348
C842 Anti-Transglutaminase IgA 47 3 348
C845 Antibodies Reticulin 47 3 348
C846 Antibodies Endomysium 47 3 348
C847 Antibodies Platelet 53 3 776
C848 Antibodies Basic Skin Membrane 73 5 200
C849 Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 35 2 493
C850 Antibodies Gliadin IgG 40 2 850
C851 Beta2 – glycoprotein antibodies 50 3 562
C852 Annexin V antibodies 50 3 562
C853 ENA – extractive nuclear antibodies screen 61 4 346
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 562
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 562
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 15 673
A069 Determination of free light chains FLC in blood 55 3 918
A070 Determination of free light chains (FLC) in urine 35 2 493
ONCOLOGICAL TESTS
C405 PSA total 29 2 066
C410 PSA free 29 2 066
C420 AFP 29 2 066
C425 CEA 29 2 066
C430 CA 125 38 2 707
C435 CA 19-9 29 2 066
C440 CA 15-3 29 2 066
C442 CA 72 - 4 40 2 850
C443 Neuron-Specific Enolase (NSE) 60 4 274
C445 B2 microglobulin 33 2 351
C820 Cyfra-21-1 40 2 850
C822 Squamous Cell Carcinoma (SCC) 39 2 778
C821 UBC (Bladder Cancer Antigen) in urine 39 2 778
C823 HE4 40 2 850
C824 Chromogranin A 55 3 918
SEROLOGY
Syphilis Diagnosis
S000 Determination of anti-cardiolipin antibodies by microreaction precipitation (RPR) (Diagnosis of syphilis) 27 1 923
S001 Determination of antibodies to Treponema pallidum (total) 27 1 923
S002 Determination of total antibodies to Treponema pallidum (quantitative) 30 2 137
S010 Determination of antibodies to Treponema pallidum by indirect hemagglutination(TPHA) 33 2 351
S011 Detection of antibodies to Treponema pallidum by the RIBT method 35 2 493
S012 Detection of antibodies to Treponema pallidum by the RIF method 20 1 425
S091 Determination of anti-Treponema pallidum IgG immunoblot 103 7 338
S092 Determination of anti-Treponema pallidum IgM immunoblot 103 7 338
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 351
A055 Antierythrocytic antibodies (screening) 40 2 850
A056 Direct Cumbs test 33 2 351
A061 Detecting Kell antigen sistem 33 2 351
A064 Phenotyping Rh and Kell 35 2 493
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 348
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 628
C004 Anti-HAV total 40 2 850
C006 Anti-HAV IgM 47 3 348
C007 Hepatitis D Virus HDV antibodies, total 28 1 995
C008 HBsAg 27 1 923
C009 HBsAg (conf.test) 47 3 348
C010 HBeAg 47 3 348
C011 HDV antibodies, IgM 28 1 995
C012 Anti-HBc total 40 2 850
C013 HEV antibodies, IgG 28 1 995
C014 Anti-HBc IgM 47 3 348
C015 HEV antibodies, IgM 28 1 995
C016 Anti-Hbe 47 3 348
C018 Anti-HBs quant. 47 3 348
C020 Anti-HCV IgG 40 2 850
C021 Anti-HCV IgM 44 3 135
C025 Anti-HCV (conf.test) 53 3 776
C026 Anti-CMV IgG 29 2 066
C028 Anti-CMV IgM 33 2 351
C030 Anti-Rubella IgG 29 2 066
C031 Anti-Parvovirus B19 IgG 40 2 850
C032 Anti Rubella IgM 33 2 351
C033 Anti-Parvovirus B19 IgM 40 2 850
C034 Anti Mumps IgG 53 3 776
C036 Anti Mumps IgM 53 3 776
C038 Anti Measles IgG 53 3 776
C040 Anti Measles IgM 53 3 776
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 348
C044 Anti-HSV 1 IgG 47 3 348
C046 Anti-HSV 1 IgM 53 3 776
C048 Anti-HSV 2 IgG 47 3 348
C050 Anti-HSV 2 IgM 53 3 776
C052 Anti-Varicella Zoster IgG 53 3 776
C054 Anti Varicella Zoster IgM 53 3 776
C058 Anti-EBV-VCA IgG 53 3 776
C060 Anti-EBV-VCA IgM 53 3 776
C094 IgG Respiratory syncytial virus 35 2 493
C096 IgM Respiratory syncytial virus 35 2 493
C152 IgG Dengue virus 25 1 781
C153 IgM Dengue virus 25 1 781
C154 Antibodies to Clostridium tetani (quantitative) 35 2 493
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 3 918
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 3 918
C450 Adenovirus infection 67 4 773
C856 Anti- encephalitis IgG 55 3 918
C857 Anti- encephalitis IgM 55 3 918
S200 Cytomegalovirus (CMV) IgG Avidity 53 3 776
S210 Rubella IgG Avidity 38 2 707
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 348
C064 Helicobacter pylori antibody blot 80 5 699
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 348
C080 Mycobacterium tuberculosis antibodies total 53 3 776
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 4 773
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 4 773
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 4 773
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 9 261
C090 Borrelia burgdorf. IgG (qual) 67 4 773
C091 Borrelia burgdorf. IgM (qual) 67 4 773
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 781
C165 Serological diagnosis of borreliosis (immunochip) in blood 13 926
C177 Determination of urease activity Helicobacter pylori, 13C (urease respiratory test) 35 2 493
C519 Anti IgG Legionella pneumophila (qual.) 89 6 340
C522 Anti IgM Legionella pneumophila (qual.) 89 6 340
C645 Brucella IgG 67 4 773
C647 Brucella IgM 67 4 773
D070 Chlamydia pneumoniae IgA 53 3 776
D071 Chlamydia pneumoniae IgG 53 3 776
D072 Anti IgM Chlamydia pneumoniae 53 3 776
D073 Chlamydia psittaci IgG (qual) 67 4 773
D074 Chlamydia psittaci IgM (qual) 67 4 773
D077 Chlamydia psittaci IgA (qual) 67 4 773
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 069
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 712
D110 Mycoplasma pneumoniae IgA (quant) 40 2 850
D115 Mycoplasma pneumoniae IgG (qual) 40 2 850
D120 Mycoplasma pneumoniae IgM (qual) 40 2 850
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 137
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 137
D322 AB Shigella flexneri (total) 60 4 274
D323 AB Shigella sonnei (total) 60 4 274
S070 Ureaplasma urealiticum IgA 67 4 773
S075 Ureaplasma urealiticum IgG 67 4 773
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 567
S232 Anti-Salmonella Typhi Vi-antigen 22 1 567
S233 Anti-Corinebacterium Diphtheriae 22 1 567
C053 Helicobacter pylori IgM 44 3 135
C063 Helicobacter pylori IgA 44 3 135
C103 Immunoblot Borrelia burgdorferi IgG 60 4 274
C104 Immunoblot Borrelia burgdorferi IgM 60 4 274
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 712
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 712
S006 Antigen Legionella pneumophila in urine 30 2 137
S007 Determination of antigen Legionella pneumophila in urine (express test) 25 1 781
S008 Determination of streptococcus pneumoniae antigen 25 1 781
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 4 773
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 4 773
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 4 773
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 4 773
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 348
D312 Lamblia intestinalis IgM 47 3 348
D315 Antibody to ascaris antigen IgG (qual.) 40 2 850
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 4 773
D325 Antibodies to Opistorchis IgG (quantitatives) 67 4 773
D326 Antibodies to Toxocara IgG (quantitative) 67 4 773
D327 Antibodies to Trichinella lgG (quantitative) 67 4 773
D328 Antibodies Ascaris IgG (quantitative) 67 4 773
D329 The blood test for trichinosis (rostirolla) 18 1 282
D330 The blood test for toxocariasis (rostirolla) 18 1 282
D331 Blood test for clonorchiasis (IgG) by ELISA 24 1 710
D332 The blood test for anisakis (IgG) by ELISA 24 1 710
C049 Strongyloides stercoralis antibodies 44 3 135
C051 Taenia solium antibodies, IgG 44 3 135
C055 Fasciola hepatica antibodies, IgG 44 3 135
C057 Schistosoma mansoni antibodies, IgG 44 3 135
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 066
C024 Toxoplasma gondii IgM (qual) 38 2 707
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 135
S230 Trichomonas antibodies 30 2 137
S220 Toxoplasma IgG Avidity 46 3 277
C625 Entamoeba sp AB (total) 80 5 699
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 1 923
C205 Total T3 27 1 923
C210 Free T3 27 1 923
C215 Total T4 27 1 923
C220 Free T4 27 1 923
C222 Calcitonin 40 2 850
C223 Thyroglobulin 40 2 850
C224 Thyroid Binding Globulin (TBG) 40 2 850
Reproduction
B151 Dihydrotestosterone 53 3 776
C100 Follicle stimulating hormone 29 2 066
C105 Luteinising hormone 29 2 066
C106 Globulin, linking sex hormones (SHBG) 47 3 348
C110 Testosterone 29 2 066
C115 Prolactin 29 2 066
C117 Testosterone Free 47 3 348
C125 Estradiol 29 2 066
C126 Estriol Free 38 2 707
C130 Progesterone 29 2 066
C141 Inhibin В 93 6 625
C143 AMH (Anti-Mullerian Hormone) 93 6 625
C159 Definition of Macroprolactin (includes the definition of prolactin) 10 712
C227 Androstenedione 60 4 274
C400 Beta HCG 33 2 351
C404 Androstanediol glucuronide 50 3 562
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 80 5 699
IVF83 Evaluation of ovarian reserve 197.6 14 077
AMH (Anti-Mullerian Hormone)
Follicle stimulating hormone
Fertility specialist consultation
C460 Determination of chorionic gonadotropin, (free Beta-subunit), ASTRAIA program 67 4 773
C461 Determination of plasma protein A (PAPP-A), ASTRAIA program 67 4 773
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 707
B531 17-alpha-Hydroxy-Progesteron 29 2 066
B536 Free cortisol (urine, 24h) 40 2 850
C120 Cortisol 29 2 066
C135 Dehydroepiandrosterone 33 2 351
C140 Adrenocorticotrophin 53 3 776
C160 Determination of polyunsaturated fatty acids of the Omega-3 family: docosahexaenoic (DHA), eicosapentaenoic (EPA) - in the blood (membrane, lipoprotein and free fatty acid complex) 65 4 631
C161 Calculation of the index Omega-3 - ratio of eicosapentaenoic acid (EPA), docosapentaenoic (DPA) and docosahexaenoic acid (DHA) fatty acids to total fatty acid content in the whole blood and erythrocyte membranes Score vozniknoveriya risk of cardiovascular disease and myocardial infarction 72 5 129
C162 Determination of polyunsaturated fatty acids of the Omega-6 family: linoleic (LA), gamma-linolenic (GLA), arachidonic (AA) acids - in the blood (membrane, lipoprotein and free-fatty acid complex) 65 4 631
C163 Determination of polyunsaturated (essential) fatty acids of omega-3 and omega-6 family. Calculated indices (omega-3 index) and omega-3 to omega-6 ratio. The index of the risk of complications of cardiovascular diseases. 134 9 546
C452 Determination of cortisol in saliva 25 1 781
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 274
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 115 8 192
C462 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 114 8 121
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 9 047
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 9 047
G123 Mucoviscidosis CFTR 300 21 372
G423 A study of the fragmentation of sperm DNA by the method of SCD 265 18 878
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 265 18 878
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 277
C132 Parathormone 47 3 348
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 135
C147 Bone resorption - deoxypiridinolin 67 4 773
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 5 699
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 277
B527 Somatomedin-C 46 3 277
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 2 850
B533 Proinsulin 60 4 274
B534 С-peptide 47 3 348
B539 Antibody-GAD 53 3 776
C108 Leptin 53 3 776
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 343
C158 Melatonin 48 3 419
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 3 776
BIOGENIC AMINES
C700 Serotonin 60 4 274
C800 Histamine 60 4 274
C900 Tryptase 75 5 343
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C157 Catecholamines and serotonin 36 2 565
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 274
C172 Determination of metabolites of biogenic amines: homovanilic acid (GVK), vanillin-mandelic acid (IUD), 5-hydroxyindoleacetic acid (5-НIАА) - in the urine 20 1 425
C173 Definition of free fractions of a metanefrin and normetanefrin (nonconjugated with SO4) in urine 23 1 638
C174 Determination of total epinephrine and norepinephrine metabolites: metanephrine, normetanephrine (free and conjugated with SO4) in urine 23 1 638
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 425
C311 Specific IgE for Allergen Mix / qual 33 2 351
C312 Single recombinant allergic components, inhalation (One name) 20 1 425
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 784
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 425
C315 General Inhalation Allergy Panel 160 11 398
C340 General Food Panel 160 11 398
C350 Allergy Panel/ primary screening 120 8 549
C351 Allergy pediatric panel, IgE (20 allergens) 156 11 113
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 1 995
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 567
C362 Antibacterial drugs (antibiotics) (specific IgE), one name. 10 712
C363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 10 712
C364 Local anesthetics (specific IgE). One name. 10 712
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 19 1 354
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 18 1 282
C367 Local anesthetics (specific IgG). One name. 18 1 282
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 1 923
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 567
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 30 277
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 855
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 22 797
C463 Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 300 21 372
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 493
P019 DNA Salmonella species in stool 25 1 781
P021 Colibacillosis 40 2 850
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 778
P009 Mycoplasma pneumoniae DNA 22 1 567
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 4 773
P030 HSV I & II 20 1 425
P031 Human Papilloma virus 31, 33 20 1 425
P032 Human Papilloma virus 6,11 20 1 425
P033 Herpes Simplex virus II 20 1 425
P035 H. Papilloma virus 16, 18 20 1 425
P042 Varicella-Zoster virus 20 1 425
P070 Cytomegalovirus 20 1 425
P080 Epstein-Barr virus 20 1 425
P105 Human Papilloma virus sp. 20 1 425
P004 Rubella Virus in blood (qual) 40 2 850
P120 Herpes Simplex virus VI (qual) 18 1 282
P125 Enterovirus (RNA) 33 2 351
P126 DNA Pneumocystis carinni 17 1 211
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 562
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 4 987
P129 RNA Zika virus (blood) 80 5 699
P130 RNA Zika virus (ejaculate) 33 2 351
P131 RNA Zika virus (Amniotic fluid) 33 2 351
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 4 987
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 137
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 069
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 54 3 847
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 425
P036 M.Tuberculosis-M.bovis 22 1 567
P038 Streptococcus group A (pyogenes) 22 1 567
P065 Listeria monocytogenes 22 1 567
P075 Pseudomonas aeruginosa 22 1 567
P085 Bordetella pertussis (PCR) 22 1 567
P095 Helicobacter pylori 38 2 707
P097 Haemophilus influenzae 20 1 425
P098 Streptococcus pneumoniae 20 1 425
P099 DNA Treponema pallidum 20 1 425
P103 Legionella pneumophila 10 712
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 712
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 425
P005 Mycoplasma hominis 20 1 425
P006 Mycoplasma genitalium 20 1 425
P015 Ureaplasma species 20 1 425
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 425
P020 Neisseria gonorrhoeae 20 1 425
P025 Gardnerella vaginalis 20 1 425
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 425
P012 Toxoplasma gondii 22 1 567
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 567
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 3 776
P045 Hepatitis B qualitive (HBV-DNA) 33 2 351
P050 Hepatitis C quant. (HCV-RNA) 253 18 023
P055 Hepatitis C qualitive (HCV-RNA) 38 2 707
P060 HCV-RNA (genotype determination) 40 2 850
P061 Hepatite G qual. (HGV-RNA) 40 2 850
P062 Hepatite D qual. (HDV-RNA) 40 2 850
P008 Hepatitis A Virus RNA (HAV-RNA) 40 2 850
P007 Determination of DNA of hepatitis TT virus (qual.) (TTV-DNA) 33 2 351
P063 Genotype of hepatitis B 35 2 493
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 343
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 13 250
P132 Definition of HIV RNA (type 1) (quantitative) 76 5 414
GENETIC ANALYSIS
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 10 686
G122 SNP identification in human IL28B gene 60 4 274
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 16 385
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 14 960
G136 FISH panel Myelodysplastic syndrome (6 probes) 245 17 454
G137 CYP2D6 analysis polymorphisms 140 9 973
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 30 633
G139 Familial adenomatous polyposis , polypoid colon cancer 430 30 633
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 40 891
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 58 416
G156 BRCA1 и BRCA2 polymorphism 225 16 029
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 71 239
G159 Sequence SCN1 A (Dravet syndrome) 825 58 772
G160 Fragile X mental retardation syndrome (methylation) 188 13 393
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 18 736
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 121 106
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 9 617
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 2 850
G165 Paternity test 480 34 195
G167 Non Invasive Fetal Rhesus factor Determination 188 13 393
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 10 686
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 800 56 991
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 800 56 991
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 74 089
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 49 867
G197 Calreticulin (CALR) 77 5 485
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 587 41 817
G216 Genetic predisposition to breast cancer and ovarian cancer 120 8 549
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 16 385
G232 Stomach cancer 454 32 343
G233 Pancreas cancer 98 6 981
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 590 42 031
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 14 248
G254 Sensorineural hearing loss 40 2 850
G255 Muscle atrophy 71 5 058
G256 Long QT syndrome 95 6 768
G264 Lactose intolerance 67 4 773
G265 Gilbert's syndrome - a confirmatory test 40 2 850
G268 Psoriasis 71 5 058
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 43 3 063
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 40 2 850
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 11 826
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 195 13 892
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 220 15 673
G289 Activity GATA2 gene for prostate cancer (blood test) 195 13 892
G290 Activity IGF1 gene for prostate cancer (blood test) 195 13 892
G291 Activity IGF2 gene for prostate cancer (blood test) 195 13 892
G292 Activity IL4 gene for prostate cancer (blood test) 195 13 892
G293 Activity IL10 gene for prostate cancer (blood test) 195 13 892
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 311 22 155
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 117 8 335
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 600 42 743
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 1000 71 239
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 510 36 332
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1550 110 421
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2660 189 496
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4430 315 589
G308 PGD ​​monogenic diseases 1 category of complexity 1330 94 748
G309 PGD ​​monogenic diseases 2 category of complexity 2215 157 795
G310 PGD ​​monogenic diseases 2 category of complexity 3325 236 870
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 435 30 989
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 535 38 113
G315 Full sequencing of exome 2105 149 958
G316 Panel "Diseases of conjunctive tissue" 640 45 593
G317 Panel "Patrimony of cardiopathy" 635 45 237
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 645 45 949
G319 Search for mutations in the gene CAV 3 135 9 617
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 43 100
G321 Panel "Hypertension" 80 5 699
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 9 973
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 360 25 646
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 180 12 823
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 555 39 538
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 245 17 454
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 170 12 111
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 170 12 111
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 800 56 991
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 580 41 319
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 245 17 454
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 16 385
G333 Myriad MyRisk 3495 248 981
G334 Myriad BRCA1 Analysis 2145 152 808
G335 Myriad BRCA2 Analysis 2225 158 507
G336 Myriad COLARIS PLUS 2935 209 087
G337 Myriad MLH1 Analysis 1830 130 368
G338 Myriad MSH2 Analysis 1595 113 626
G339 Myriad MSH6 Analysis 1950 138 916
G340 Myriad PMS2 Analysis 1830 130 368
G341 Myriad MYH Sequence Analysis 1751 124 740
G342 Myriad Comprehensive MELARIS 1667 118 756
G343 Myriad Comprehensive PANEXIA 2935 209 087
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 343
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 10 686
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 65 4 631
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 180 12 823
G355 Myriad BRAC Analysis 2540 180 947
G356 Myriad Single-Site BRACAnalysis 1184 84 347
G357 Myriad MultiSite 3 BRACAnalysis 1387 98 809
G358 Myriad Reflex BRACAnalysis 2305 164 206
G359 Myriad BRACAnalysis Rearrangement Test (BART) 1476 105 149
G360 Myriad Single-Site COLARIS 1184 84 347
G361 Myriad COLARIS AP PLUS 2540 180 947
G362 Myriad Single-Site COLARIS AP 1184 84 347
G363 Myriad MYH Mutation Panel 1100 78 363
G364 Myriad Reflex MYH Sequence Analysis 1500 106 859
G365 Myriad Single-Site MELARIS 1184 84 347
G366 Myriad Single-Site PANEXIA 1184 84 347
G367 Myriad PALB2 Analysis 1880 133 930
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 74 089
G376 Molecular karyotyping abortion material OPTIMA 310 22 084
G377 Chromosomal micrometrical analysis of abortive material Standard 530 37 757
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 600 42 743
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 454 32 343
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 460 32 770
G388 The allocation and storage of DNA 23 1 638
G389 Panel "Disorders of hemostasis" 30 tokens 210 14 960
G391 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy at 21 chromosome (Down syndrome) + sex determination 308 21 942
G392 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + definition of sex (for pregnancy two fruits) 532 37 899
G393 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + numerical disorders of sex chromosomes and sex determination 532 37 899
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 10 472
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 9 475
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 17 382
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 25 290
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 25 290
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 19 733
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 26 074
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 22 084
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 15 815
G425 The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 220 15 673
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 14 248
TISSUE TYPING
G020 HLA TYPING B27 200 14 248
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 5 699
M003 Bacterioscopic stained smear 30 2 137
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 348
M010 Mycology & Fungigram 90 6 412
M100 Disbacteriosis 107 7 623
M130 Corynebacterium diphtheriae (BL) 29 2 066
M135 Enteropathogenic bacteria (BD) 35 2 493
M170 Staphylococcus aureus 52 3 704
M350 Yersinia enterocolitica (stool culture) 52 3 704
M560 Listeria (with resistance) 38 2 707
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 53 3 776
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 53 3 776
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 18 1 282
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 425
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 18 1 282
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 16 1 140
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 15 1 069
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 10 686
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 124
M151 Microbiology of blood by fungi (double reseeding) 130 9 261
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 5 699
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 9 261
M156 Mycology of sputum by fungi, microscopy and culture 80 5 699
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 9 261
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 7 836
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 549
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 5 699
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 124
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 549
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 4 987
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 5 699
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 412
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 8 192
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 5 699
COMPLEX LABORATORY TESTS
K011 Fibro Test/ Acti Test 300 21 372
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 27 071
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 340
G100 TIMP-2 - study of lung cancer invasiveness 89 6 340
G008 TGF B - study of prostate cancer invasiveness 89 6 340
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 562
G010 BRCA1 4153delA 50 3 562
G011 BRCA1 185delAG 50 3 562
G012 BRCA1 C61>G 50 3 562
G014 BRCA1 2080delAA 50 3 562
G015 BRCA2 6174delT 50 3 562
G016 BRCA2 9318 delAAAA 50 3 562
G021 CHEK2 ivs2+1G>A 50 3 562
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 6 055
G053 BCR-ABL p190 t(9;22) 85 6 055
G054 BCR-ABL p230 t(9;22) 85 6 055
MUTATIONS, CHIMERISM
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 10 686
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 340
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 274
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 3 989
G107 Deletion in 12 exon gene Jak-2 kinase 80 5 699
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 7 480
G152 Germinal mutation 60 4 274
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 7 480
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 731 52 076
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 90 6 412
G374 Prenatal DNA diagnosis (Wilson's Disease) 180 12 823
G381 PMP22(1.5-MB Del) 29 2 066
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 29 2 066
G383 PMP22 (1-BP INS, 325G; rs80338763) 29 2 066
G384 PMP22 (Ala67Thr: rs104894623) 29 2 066
G385 PMP22 (EX2-3DEL; nsv1197510) 29 2 066
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 6 055
G387 Genotyping on the RH factor, including heterozygous carrier 126 8 976
G390 Panel "Phacomatosis and hereditary cancer" 631 44 952
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 9 047
G408 Analysis of carriers of spinal ametropia 144 10 258
G409 Screening for hereditary diseases (2500 genes) 632 45 023
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 274
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 14 889
G412 Search 9 most frequent mutations in the CYP210HB gene 144 10 258
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 12 182
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 5 557
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 78 933
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 86 769
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 108 853
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 116 761
G420 Confirmation of previously found mutation sequencing by Sanger 115 8 192
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 115 8 192
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 665 47 374
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 90 6 412
G432 Neurodegenerative diseases - APOE gene genotyping 56 3 989
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 115 8 192
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 270 19 235
G435 BAS - screening of the coding region of the SOD1 gene 270 19 235
G442 The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 170 12 111
G443 Complex genetic research: hereditary diseases of the gastrointestinal tract 635 45 237
G444 Search for mutations in 63 genes responsible for SPG in spastic paraplegia of Strumpel 645 45 949
G445 Full genome sequencing GenomeUNI 1840 131 080
G446 Research on the genome FERTY 1440 102 584
G447 Search for mutations in the FKTN gene (Muscular dystrophy of the Fukuyama type) 400 28 496
G448 Finding a relative’s identified mutations in this family (Muscular dystrophy of the Fukuyama type) 90 6 412
G449 Search for frequent mutations in CAPN3, FKRP, ANO5, SGCA genes (muscular dystrophy of the lumbar) 105 7 480
G450 Search for mutations in genes CAPN3, DMD, EMD, SGCG, SGCA, SGCB,SGCD, TCAP, FKRP, POMT1, ANO5, FKTN, ISPD, LMNA, CAV3 (muscular dystrophy of the lumbar) 645 45 949
G451 Search for mutations in the FKRP gene (muscular dystrophy of the lumbar) 130 9 261
G452 Search for mutations in the SGCA gene (muscular dystrophy of the lumbar) 200 14 248
G453 Search for mutations in the SGCB gene (muscular dystrophy of the lumbar) 200 14 248
G454 Search revealed in this family mutations in a relative (muscular dystrophy of the lumbar) 90 6 412
G455 Prenatal DNA diagnosis (muscular dystrophy of the lumbar) 180 12 823
G456 Finding mutations in the EMD gene (Emery-Dreyfus muscular dystrophy) 130 9 261
G457 Finding mutations in the LMNA (Emery-Dreyfus muscular dystrophy) 335 23 865
G458 Finding mutations in the FHL1 gene (Emery-Dreyfus muscular dystrophy) 270 19 235
G459 Search revealed in this family mutation in a relative (Emery-Dreyfus muscular dystrophy) 65 4 631
G460 Prenatal DNA diagnosis Emery-Dreyfus muscular dystrophy 180 12 823
G461 Search for deletions and duplications in the DMD gene in boys (Duchenne/Becker muscular dystrophy) 200 14 248
G462 Search deletions and duplications in the patient's relatives in the female line (Duchenne/Becker muscular dystrophy) 235 16 741
G463 Search for point mutations in the DMD gene (Duchenne/Becker muscular dystrophy) 645 45 949
G464 Search for a point mutation identified in this family from a relative (Duchenne/Becker muscular dystrophy) 65 4 631
G465 Prenatal DNA diagnosis (Duchenne/Becker muscular dystrophy) 180 12 823
G466 Determination of mutations in MYD88 GENE (L265P) (associated with primary resistance to ibrutinib) 130 9 261
G467 Determination of B-cell clonal rearrangement of heavy chain IG (IgH) genes 138 9 831
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
EXPRESS DIAGNOSTICS
E002 General Biochemistry express screening 122 8 691
C-Reactive Protein
Albumin
Bilirubin total
Alanine Amino Transferase
Asparate Amino Transferase
Gamma Glutamyle Transferase
Alk. Phosphatase
Amylase
Glucose
Urea
Creatinine
Calcium
Uric acid
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 15 174
H250 Histology of tumor surgical samples 389 27 712
H299 Intraoperative (urgent) histology and cytology 200 14 248
H270 Histology of breast wide local excision (lumpectomy) specimen 389 27 712
H271 Histology of mastectomy speciment 367 26 145
H272 Histology of sentinel lymph node with IHC if necessary 280 19 947
H273 Histology of lymph node dissection speciment 213 15 174
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 9 047
M202 Hystology with supplementary staining for helicobacter pylori 227 16 171
M203 Multiple histology 3 samples and more 344 24 506
H204 Histology of the prostate punctates 358 25 504
H205 Histology of scrapings of the uterus 213 15 174
H206 Histology of the mammary gland punctates 213 15 174
H207 Histology of liver bioptates 213 15 174
H208 Histology of CT-guideline needle biopsy 397 28 282
H209 Histology of skin (PUNCH-biopsy) 213 15 174
H210 Histology of skin tumors 198 14 105
H211 Histology of bone marrow patho bioptate 280 19 947
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 11 113
H231 Consultation with the making of histology specimens with paraffin blocks 224 15 958
H232 Consultation with the making of specimens and immunohistochemistry 358 25 504
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 27 712
H234 Consultation histological slides by a qualified pathologist USA, University of Southern California 445 31 701
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 554
CYTOLOGY
M300 Citology / 1 lame 75 5 343
M301 Cytologic cervical smear (Pap Smear) 94 6 696
M302 Integrated cytology PAP-test and HPV typing 117 8 335
M303 Complex immunocytochemical study of thyroid neoplasms 450 32 058
M304 Complex cytological and immunocytochemical examination of pleural fluid 110 7 836
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 557
Z303 Cytology of the mammary gland 75 5 343
Z304 Cytology of the thyroid gland punctate 117 8 335
Z305 Cytology of liquid 78 5 557
Z306 Cytology of endoscopic material 56 3 989
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 557
Z308 Cytology of surgical samples 78 5 557
Z309 Cytology of the lymph nodes punctate 94 6 696
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 557
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 22 1 567
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 19 804
I002 Immunohistochemical differential diagnosis of tumors 389 27 712
I003 Immunohistochemistry of one marker panel differential diagnosis 213 15 174
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 32 556
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 256 18 237
I006 Immunocytochemistry 256 18 237
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 15 673
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 18 237
I009 Immunohistochemical study of PDL-1 gene expression 275 19 591
I010 Immunohistochemical study of up to 5 antibodies 229 16 314
I011 Immunohistochemical study from 5 to 10 antibodies 361 25 717
I012 Immunohistochemical study from 10 to 20 antibodies 541 38 540
I013 Complex histological and immunohistochemical study of biopsies of the prostate 450 32 058
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 11 113
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 28 496
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 305 21 728
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 308 21 942
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 313 22 298
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 313 22 298
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 313 22 298
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 301 21 443
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 315 22 440
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 315 22 440
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 20 446
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 20 446
G202 EGFR gene amplification (sensitivity to cetuximab) 259 18 451
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 12 681
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 16 812
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 7 979
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 23 366
G207 Determination of the methylation status of the promoter body and MGMT gene 177 12 609
G368 Tissue test in ovarian cancer treatment 3213 228 891
G369 Agression degree in prostate cancer 4310 307 041
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 4310 307 041
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 173 538
G404 Express research of additional biomarkers 226 16 100
G405 Biological profiling of tumor (Caris Target Now) only NGS 3500 249 337
G406 Biological profiling of tumor (Caris Target Now) full profile 6000 427 435
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 78 933
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 175 12 467
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 175 12 467
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 145 10 330
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 150 10 686
G438 Immunohistochemical study of PDL-1 gene expression 165 11 754
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 737 52 503
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1550 110 421
G441 Comprehensive genetic study of thyroid tumors by NGS 1550 110 421
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 305 21 728
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 17 739
I504 Translocation in synovial sarcoma SYT/SSX 305 21 728
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 305 21 728

    Mobile application EMC